The disparity index is an expression of histocompatibility difference between two siblings with identical human leukocyte antigen (HL-A) type who are nonreactive in mixed leukocyte culture (MLC) test. This index is derived from a third-party MLC test. The disparity index was found to be correlated with the severity of graftversus-host reaction in bone marrow transplantation between HL-A-identical siblings. The disparity index may prove to be a useful means of predicting the severity of graft-versus-host reaction and the outcome of bone marrow graft when HL-A-and MLC-matched sibling donors are studied. The third-party MLC test is offered as a new method of histocompatibility testing. It may provide a useful model for the study of immunogenetics relative to so-called weaker histocompatibility determinants in man and experimental animals.
Since it has been shown in man that lymphocytes carry most (if not all) of the transplantation antigens (1, 2), a proper and precise typing of human lymphocytes would naturally provide a useful means of selecting donor and recipient for the transplantation of tissues and organs in man.
After the demonstration by Dausset (3) of the existence of leukocyte isoantigens in man, more than 30 antigens of the human leukocyte have been identified that belong to the human leukocyte antigen (HL-A) system (4) . The extreme polymorphism of the HL-A system makes it difficult to find an HL-A identical donor outside family members.
In the mixed leukocyte culture (MLC) test (5, 6) , the sum total of antigenic differences between two individuals is measured regardless of the kind and the numbers of different antigens involved. Genetic studies of the MLC test suggested that a minimum of 20 different alleles is involved (7) , and that the same chromosomal region controls both the HL-A system and MLC reaction in man (8) . Like the typing of HL-A antigens, it is extremely rare to find MLC-matched pairs outside family members. A nonstimulatory MLC is regularly found in identical twins and in HL-A-identical siblings with rare exceptions (9) .
Within family members, the prolongation of skin graft and kidney graft are well correlated with the identity of HL-A type of leukocytes and reactivity of leukocytes in MLC tests (10) (11) (12) . However, these correlations have been generally poor when the donor is outside the family (13, 14) . For the practical purpose, at the present time, the best match between the donor and recipient of a transplant is a donor (a) having HL-A identity, (b) having MLC nonreactivity, and (c) deriving from among family members. Even among pairs that fulfill all these three conditions, the graft-versus-host reaction may take place in the recipient of bone marrow transplant, or the grafted organs may gradually lose function unless the donor is an identical twin of the recipient. Thus, it must be assumed that another yet unknown factor(s) must exist that influences the outcome of organ, tissue, and cellular grafts. It is our purpose here to report a new method of histocompatibility testing that we believe will further discriminate the degree of incompatibility in HL-A identical, MLC nonreactive sibling pairs.
MATERIALS AND METHODS
Mixed leukocyte culture was performed according to the methods of Sengar et al. (15) 
RESULTS
An example of calculation of the disparity index from the results of a third-party MLC test is shown in Table 1 , i.e., XAm = 1276, XBm = 1110. Therefore, DI = 0.14. Table 2 shows the results of a third-party MLC test in three HL-A identical siblings (A, B, and C) in a family with two unrelated individuals (XI, X2). The disparity indices between AB, BC, and AC are 0.63, 0.62, and 0.01 for Xi and 0.63, 0.62, and 0.03 for X2, respectively. There is a similarity between the disparity indices for Xi and those for X2. (8) Tu families] were the HLA-and MLC-identical donors and recipients of bone marrow transplantation for reconstitution of combined immunodeficiency disease. The severity of the graft-versus-host reaction appeared to be correlated well with the disparity index between the donor and recipient, i.e., the smaller the index, the lesser the graft-versushost reaction.
DISCUSSION
The importance of pursuing improved histocompatibility testing has been strongly affirmed since the individual specific tissue isoantigens (histocompatibility antigens) are under dominant genetic control. These histocompatibility antigens are mainly responsible for provoking the complex events involved in rejection of grafted tissues. It seems from both clinical and experimental study that lesser immunogenetic differences between a donor and recipient can contribute to better prognosis of the fate of grafted tissue.
Currently, available methods of testing histocompatibility can be divided into two categories: (a) the histocompatibility typing and (b) histocompatibility matching. The term "typing" is used for techniques that provide identification of (18, 19) compares the accelerated rejection of second skin grafts by the indifferent recipient, a phenomenon clearly dependent upon antigens that are shared by the donor of the initial graft (the intended recipient) and the potential donor. The normal lymphocyte transfer (NLT) test (20, 21) measures the skin reaction (delayed type) of potential donor upon intradermal injection of leukocytes from a potential recipient. The lesser the degree of the reaction, the longer is the predicted survival of the graft. The skin reaction is believed to be due to a local graft-versus-host reaction elicited by the injected immunocompetent lymphocytes. The major disadvantages of both methods are the potential hazard of transmitting infectious agents to the test subject and the qualitative nature of the assay. The one-way MLC test by either irradiated or mitomycin-treated cells as a stimulator (22, 23) measures the unidirectional reaction of one individual's cells against allogeneic leukocytes in vitro. Since this test is performed in vitro, the danger of cross infection is eliminated and the test is quantifiable. The ready access to leukocytes provides a further advantage of MLC testing over the other two matching methods. The over-all correlation between the MLC test, the survival of skin and kidney graft, and the HL-A typing have been shown generally to be good among the members of the same family. The correlation is generally poor between unrelated individuals. At present, the best possible match, besides identical twins, is siblings with identical HL-A type and a nonreactive MLC test.
The third-party MLC test described herein, we contend, provides an additional method of histocompatibility matching that will further discriminate antigenic disparity between siblings with identical HL-A type and nonreactive MLC test. In the third-party MLC test, the stimulating capacity (hence the antigenicity) of leukocytes from two siblings against the leukocytes of the same unrelated individual is measured. Antigenic differences between the leukocytes of two donors are thus reflected in the differences of stimulation of the leukocytes of the third party. The third-party MLC test is similar to the third-man test in a sense that the histocompatibility antigen(s) of both prospective donor and recipient are tested upon a third-party individual. However, in contrast to the third-man test, a prior sensitization of the third individual is not required for this analysis. Further, in the third-man test the similarity between the donor and the recipient is sought in the accelerated rejection of skin graft, while in the third-party MLC test more direct measure of the genetic disparity between the donor and recipient is provided.
Neither the normal lymphocyte transfer test nor the thirdparty MLC test requires presensitization. The two methods differ in that the responding cells in the third party MLC test are the lymphocytes of the third party, whereas in the normal lymphocyte transfer test, the responding cells must be the immunocompetent lymphocytes from the prospective recipient of the organ that provokes the reaction in the skin of the prospective donor. For two reasons, the normal lymphocyte transfer test is not suitable for the matching of donor and recipient for bone marrow transplantation: (a) the hazard of the transplant relates to the graft-versus-host reaction produced by donor cells where the recipient is often immunoincompetent and (b) in present marrow transplantations, the recipient regularly is lacking the thymus-derived immunocompetent lymphocyte that elicits delayed type skin reaction in the test subject.
At present, the third-party MLC test is applicable mainly in siblings with identical HL-A type, whose leukocytes are nonreactive in the MLC test. In these conditions, it is assumed that the major histocompatibility antigens are identical. Therefore, the third-party MLC test and the disparity index derived therefrom probably reveal differences in minor histocompatibility antigens. Nonetheless, this method of histocompatibility matching may provide a new approach to the analysis of immunogenetics in man and experimental animals.
Our preliminary studies of the disparity index and severity of graft-versus-host reaction in patients after bone marrow transplantation suggest that the disparity index between the donor and the recipient may have predictive value on the severity of graft-versus-host reaction in the recipient. Since the graft-versus-host reaction is the single most important limiting factor in successful marrow transplantation, the disparity index should contribute a useful means of selecting donors, calculating the number of marrow cells that can be safely transplanted, and thus minimize graft-versus-host reactions. We would predict that the third-party MLC test will provide a useful additional means of selecting donors among both related and unrelated individuals.
The results of third-party MLC test in identical twins indicate that the disparity index is influenced by genetically controlled factor(s). The major factors controlling the disparity index could be minor histocompatibility antigens or differences controlled by the recently described "MLC locus" or "hypersensitivity delayed reaction (HDR) locus" (24) . That the severity of the graft-versus-host reaction was found to be related to the disparity index between donor and recipient leads us to postulate that a separate locus controlling the disparity index may exist. This locus, however, could be the same or could be closely related to the "HDR locus." Further studies to analyze the genetic control of the third-party MLC test in man and experimental animals should be performed.
